Lipids are fundamental building blocks of cells and their organelles, yet nanoscale resolution imaging of lipids has been largely limited to electron microscopy techniques. We introduce and validate a chemical tag that enables lipid membranes to be imaged optically at nanoscale resolution via a lipid-optimized form of expansion microscopy, which we call membrane expansion microscopy (mExM). mExM, via a novel post-expansion antibody labeling protocol, enables protein-lipid relationships to be imaged in organelles such as mitochondria, the endoplasmic reticulum, the nuclear membrane, and the Golgi apparatus. mExM may be of use in a variety of biological contexts, including the study of cell-cell interactions, intracellular transport, and neural connectomics.
form of expansion microscopy (membrane expansion microscopy, or mExM) optimized for the imaging of lipid membranes as well as the antibody labeling of protein targets.
Traditional fluorescent membrane labeling probes (i.e., DiI and DiO) consist of long hydrophobic chains bearing fluorophores 8 , which preferentially localize to and diffuse within membranes 9 . Recent iterations of such molecules (i.e., FM1-43FX 10 and mCLING 11 ) also include hydrophilic moieties, like primary amines, to permit them to diffuse more freely in three dimensions throughout tissues prior to reaching their membrane targets. Inspired by these examples, which are not directly compatible with expansion microscopy, we sought to develop a membrane probe that is compatible with ExM chemistry, and in particular one that can achieve dense enough membrane coverage to support nanoscale resolution imaging and allow continuous tracing of membraneous structures (which degrades when stain density is insufficiently high). To achieve this, we designed a stain with the following features: (1) amphiphilicity, to support both lipid membrane intercalation and diffusion in 3D tissues, (2) a chemical handle for chemoselective conjugation of a fluorophore following the formation of the expandable hydrogel network, so that the molecular weight of the initial label can be kept as small as possible to facilitate diffusion, and (3) a polymer-anchorable handle for binding the probe to the ExM-gel matrix, to allow expansion.
We designed our membrane probe (Fig. 1a , lower left) to contain a chain of lysines, since they contain primary amines on their side chains that could serve as sites for binding to a polymeranchorable handle, such as acryloyl-X (AcX), previously used to attach proteins via their amines to the in situ synthesized ExM hydrogel 3 . The amines are also positively charged, which can help promote interactions with negatively charged membranes 12 . To achieve lipid membrane intercalation, we included a lipid tail on the amine terminus of the lysine chain, with a glycine in between to provide mechanical flexibility 13 . Such glycine linkers are encountered next to lipid tails in many post-translationally modified proteins 14 . We limited the size of the label to ~1kDa, to allow fast diffusion throughout tissue and dense labeling of membranes; this limited us to having ~5 lysines in the backbone. We chose to use D-lysines, rather than the biologically typical L-lysines, to minimize degradation during the mechanical softening step of ExM, which in its most popular form involves a strong proteinase K digestion step. Finally, we introduced a chemical handle to the carboxy terminus of the terminal lysine. We chose to use a biotin, which could then react with one of the four binding sites of a fluorescently labeled streptavidin administered later 15 ; the remaining active sites of the streptavidin can then be reacted with further biotinylated fluorophores to amplify the brightness manyfold.
We modified the preprocessing steps of the ExM protocol to better preserve lipids, since most lipids are not fixed during conventional chemical fixation 16 . To achieve lipid retention, we introduced two practices during tissue preservation and preparation for ExM. First, we combined paraformaldehyde with a low percentage (0.1%; increasing this number to 0.2% lowered the expansion factor, indicating incomplete tissue homogenization) of glutaraldehyde during fixation, since the latter helps to stabilize lipids (likely via stabilizing surrounding proteins 16 ). Second, we maintained the temperature during tissue processing at 4 C (processing at room or higher temperatures decreased lipid signals), since lipid loss can be exacerbated by higher temperatures 17 , but at low temperatures lipids are in a more ordered state and are less likely to diffuse out of the sample 18 . In more detail: we preserved brain tissue in 4% paraformaldehyde (PFA) with 0.1% glutaraldehyde in ice cold phosphate buffered solution (PBS), sectioned the brain and washed out excess aldehydes, then applied the membrane probe (still at 4 C) at 100μM final concentration. Incubation at higher than 100μM probe concentrations yielded no change in the observed signal. We then added AcX at 4 C to make the membrane probes hydrogel-anchorable, incubated the specimen with the ExM gel monomer solution at 4 C, and finally incubated the samples at 37 C to initiate free-radical polymerization based hydrogel formation (Supp . Table 1 ). Finally, gelled samples were homogenized with a digestion buffer containing proteinase K, and post-labeled with fluorescent streptavidin (Fig. 1a , top row). Except for the pre-processing, the remainder of the stepsincubation, gelation, digestion, and expansion -are identical to earlier ExM protocols such as proExM, ensuring even and isotropic expansion.
We investigated, inspired by common lipid post-translational protein modifications, lipid tails that were both saturated and unsaturated --specifically palmitoyl 19 versus farnesyl 20 tails. To assess whether saturated vs. unsaturated lipid tails exhibited different performance, we incubated mouse brain tissue sections with 100 μ M of palmitoylated vs. farnesylated forms of our lipid stain (with an azide replacing the biotin, for simplicity). We post-labeled the lipid stains with 0.8 nm gold nanoparticles modified with a dibenzocyclooctyne (DBCO) handle, and imaged the resulting specimens with an electron microscope. We counterstained membranes with a "ground truth" electron microscopy label, osmium tetraoxide. These experiments showed that our construct indeed labeled lipids (Fig. 1b) , and also that the palmitoylated probe ( Fig. 1b) achieved denser membrane labeling than the farnesylated one (Supp. Fig. 1 ). This pattern was borne out when the stains were compared using ExM (Supp. Fig. 2 ). Thus, we chose palmitoyl as the lipid tail of our label. We tried combining a palmitoyl and a farnesyl group into a single backbone (on the N and C termini of the peptide, respectively), but observed limited tissue penetration, perhaps due to high hydrophobicity, as evidenced by probe accumulation on the surface of the tissue. We also assessed versions of the probe with vs. without the glycine linker;
omitting the glycine linker caused loss of detail (Supp. Fig. 3 ). The results of these chemical synthesis and screening steps was a glycine and penta-lysine D-peptidic backbone, with a palmitoyl lipid group on the amine-terminus and a biotin on the carboxy-terminus, with a molecular weight of 1216 Daltons, which we call pGk5b (palmitoyl-G-kkkkk-biotin; Fig. 1a , inset). We call the use of this lipid label, with lipid-preservation-optimized tissue fixation and processing as described in the previous paragraph, membrane expansion microscopy (mExM).
We have synthesized a significant amount of pGk5b and will distribute it, free of charge, to people interested in trying it out; we are also beginning the process, in parallel, of seeking a commercial vendor. mExM enabled dense labeling of membranous structures in the mouse brain that cannot be observed in unexpanded tissue ( Fig.1c ). In addition to tissue specimens ( Fig. 2) , we can use mExM to label and expand membranes of fixed cells cultured in vitro (Supp. Fig. 4 ). Samples expand 4.5 times, as expected because the core (polymerization, digestion, and expansion) of the mExM process is identical to that of earlier ExM protocols such as proExM, which have been validated to expand isotropically (with few-percent error over length scales of tens to hundreds of microns) in many cell types and tissue types 3, 21, 22 .
Immunohistochemistry-compatible mExM
Given the interactions between proteins and lipids, in support of the scaffolding of cellular signals and compartmentalization of signaling cascades, it would be desirable to jointly image lipids and proteins in the same specimen. We therefore further developed an integrated protein and lipid ExM imaging protocol. Combining antibody staining and lipid labeling was not trivial:
immunostaining protocols typically require permeabilization of samples with detergents, to enable penetration of antibodies throughout tissue 23 , but detergents will also solubilize lipids and permeabilize membranes, preventing retention of the nanoscale spatial layout of the lipid membranes 24 . We tried a variety of methods to resolve this issue. Using mild detergents (compared to those typical in immunofluorescence, e.g., Triton-X, NP-40, TWEEN) like saponin 25 resulted in antibody signals that looked punctate and dim, and compromise details of intracellular organelles. Instead, we therefore sought to immobilize the lipid probes before permeabilization and antibody labeling. To achieve this, we initially attempted re-fixing the lipid probes by exposure to 0.1% PFA, but observed loss of epitope accessibility upon immunostaining, as well as low expansion factor (x2.8) (Supp. Fig. 5a ). Alternatively, prior to forming the ExM gel, we formed a cleavable but non-expanding hydrogel (containing only uncharged acrylamide, and crosslinked with the cleavable N,N'-diallyl-tartardiamide), that could anchor the lipid labels in place prior to detergent exposure, antibody staining, gelation with an expanding gel, cleavage of the initial gel and finally expansion of the second gel. In this case, the lipid staining was preserved, but antibody labeling was dim --presumably due to diffusion limitations arising from the non-expanding gel (Supp. Fig. 5b ).
To solve these problems, we developed a post-expansion antibody labeling protocol, in which we first labeled the tissue lipids with pGk5b, synthesized the ExM gel, used high temperature and detergent (rather than epitope-destroying proteinase K) to perform the mechanical homogenization process 23 which allows isotropic expansion 3 , and then delivered antibody labels to the retained epitopes after expansion. After this homogenization process but before replacing the buffer with pure water, to achieve full 4.5x expansion, the sample expands ~2 times in the antibody labeling buffer; thus we denote this procedure as "post-expansion antibody labeling".
Our new protocol builds on the post-expansion protein-retention ExM (proExM) protocol 3 , as well as tissue proteomics protocols for formalin-fixed paraffin-embedded (FFPE) tissues [26] [27] [28] . In brief, we heat the sample for half an hour at 100 C and for 2 hours at 80 C, in a "fixation reversal" (FR) buffer 28 containing 0.5% PEG20000, 100mM DTT, 4% SDS, in 100mM Tris pH8 (Supp. Table 2 ). We found the FR buffer to work better than high-temperature treatment with alternative buffers (Citrate or Tris buffer for antigen retrieval) that caused loss of antibody staining (Supp. Fig. 6 ), or commercially available protein extraction buffers (i.e., RIPA buffer 29 and the Liquid Tissue MS Protein Prep Kit 30 ) that did not support tissue expansion.
Alternatively, the samples can be autoclaved at 121 C for 1 hour in the FR buffer. In that case, and following the observations established for the post-expansion proExM method 3 , some epitopes were not stained effectively by antibodies (Supp . Table 2) , however, perhaps because of an interaction between the FR buffer and very high temperatures.
We performed mExM with antibody staining (Fig. 1a , bottom row), using antibodies against organelle-specific membrane-localized proteins --such as calnexin for the endoplasmic reticulum (ER, Fig. 3a) , giantin for the Golgi apparatus ( Fig. 3b) , Tom20 for mitochondria ( Fig.   3c ), and NUP98 for the nuclear membrane ( Fig. 3d) . We also labeled myelin using an antibody against myelin basic protein (Fig. 3e) . In all cases, we observed clear co-localization of the lipid signals from the membranes constituting the organelles, with the antibody signals from the organelle membrane proteins.
The high resolution of mExM captured details of protein-lipid organization known to occur, but difficult or impossible to assess with conventional microscopy. For example, it is known that the endoplasmic reticulum contains components that come in close apposition with the nuclear membrane 31 , which can be observed directly with ExM ( Fig. 3a , right, yellow arrows).
Specifically, Calnexin is a lectin protein expressed primarily on the surface of the rough ER 32 , and a 3D representation of the iso-intensity profiles of Calnexin protein expression in the tissue reveals the cisternae of the ER and its co-localization with mExM-tagged ER lipids 33 (Fig.   3a (vii-ix) and Supp. Movie 1). Calnexin exhibits a peri-nuclear labeling pattern with colocalization with membrane labels -this represents a previously known sub-population of Calnexin proteins that are post-translationally modified with a palmitoyl group inside the ER and localize to contact sites of the ER with the nucleus 34 . Additionally, the Golgi apparatus, colabeled with anti-giantin and our lipid stain, is visible primarily in neuronal somas, in accordance with previous studies 35 (Fig. 3b, right) . In 3D, giantin labeling exhibits cisternal morphology that overlaps with pGK5b labeling (Fig. 3b(vii-ix) and Supp. Movie 2). Mitochondria are abundant throughout the tissue in somata, dendrites and axons. (Fig. 3c(vii-ix) and Supp. Movie 3).
Tom20 expression on the surface of mitochondria reveals individual protein clusters, consistent with other super-resolution imaging methods (Fig. 3c, right, Fig. 3c(vi) yellow arrow) 36 . Nuclear pore complexes are resolved as individual pores on the nuclear membrane ( Fig. 4d, right) , and can be seen to span the nuclear membrane when visualized in 3D ( Fig. 3d(vii-ix) and Supp.
Movie 4)
. Myelinated regions of neurons exhibit very strong membrane labeling (Fig. 3e, right) , with excellent co-localization of the protein with the membrane label ( Fig. 3e(vii-ix) and Supp.
Movie 5).
In summary, we have developed a membrane intercalating probe that enables the imaging of cellular membranes, in thick fixed tissue, in the context of a lipid-optimized form of expansion microscopy. We also developed a post-expansion antibody labeling method that allows for the joint imaging of proteins and membranes in ExM. This enables nanoscale observation of lipid membrane structures and their associated proteins at nanoscale resolution, even across large volumes, using ordinary microscopes. We hope that this will democratize and extend the study was applied to 200μm thick tissue slices from a mouse brain perfused with 4% PFA and 0.1% glutaraldehyde at 4 C, labelled with lipids for 2 days at 4 C, and labelled with 0.8nm undecagold gold nanoparticles conjugated to dibenzocyclooctyne. The tissue was post-fixed in 2% glutaraldehyde, embedded in resin, counter-labeled with osmium tetraoxide and imaged.
When labeling membranes with the palmitoylated version of the probe (pGk5), the staining is dominated by the gold nanoparticles which overlap with osmium. The osmium staining (less contrast than the nanoparticles) becomes apparent when the tissue is labeled with the farnesylated probe, which exhibits less membrane coverage than the palmitoylated one (Supp. 
Materials and Methods

Lipid Label Synthesis
The lipid labels were commercially synthesized (Anaspec). They were purified to >95% purity.
They were aliquoted into 1 mg quantities in tubes, lyophilized to solid powder, and stored at -20 C until stock solutions were prepared. For stock solutions, 1 mg of solid lipid label was dissolved in 50% DMSO and 50% ultrapure water to 10mM and stored in -20 C.
Brain Tissue Preparation
Wild type (C57BL/6, Taconic) mice were first terminally anesthetized with isoflurane. Then, 1x phosphate buffered saline (PBS) was transcardially perfused until the blood cleared. For all mExM experiments, the mice were then transcardially perfused with the fixative 4% paraformaldehyde (PFA) and 0.1% glutaraldehyde, buffered in 1x PBS. The fixative was kept on ice during perfusion. After the perfusion step, brains were dissected out, stored in the fixative at Fig. 7) . The chamber containing the tissue was then transferred over to an incubator kept at 37 C to initiate free-radical polymerization. After 2 hours, the gelation chamber containing the tissue was taken out, and the gelled tissue was cut out from the chamber to be immersed in proteinase K digestion buffer. Proteinase K (ProK; NEB, catalog no. P8107S) was stored at -20 C at 800U/ml concentration, which was then diluted in the digestion buffer at 1:100 concentration prior to use. PBS at RT before it was placed in excess water for expansion. The fluorescence of lipid labels were further amplified by labelling the gel once more with biotin labelled with Atto 565 (Atto 565-Biotin; Sigma Aldrich, catalog no. 92637-1MG-F) at 0.01 mg/ml concentration after the gel was incubated in Atto 565-Streptavidin and before it was immersed in excess water for expansion. Alternatively, instead of using Atto 565-Streptavidin, wild type streptavidin (Thermo Fisher, catalog no. S888) was used at 0.3 mg/ml with the same labelling conditions, and Atto 565 biotin was added at 0.01mg/ml. The fluorescent labels attached to the biotin alone are sufficiently bright for imaging the sample with high signal-to-noise profiles.
Immunohistochemistry-compatible mExM
The aforementioned mExM steps were carried out the same, except for the digestion step.
Instead of using the proteinase K digestion buffer, tissue was boiled in the Fixation Reversal (FR) buffer for 30 minutes at 100 C and then held for 2 hours at 80 C, or autoclaved for 1 hour A32731), and anti-Mouse Alexa Fluor Plus 647 (Thermo Fisher, A32728) were used. After antibody staining, the lipid labels that were conjugated to the gel were then labelled with streptavidin and biotin containing Atto 565 fluorophores, as described in the mExM protocol mentioned above.
Confocal and Light-Sheet Imaging
All mExM images (Figure 2a, 3 and Supp. Figure 2 , 3, 4, and 5) were taken with an Andor spinning disk (CSU-W1 Tokogawa) confocal system on a Nikon Eclipse Ti-E inverted microscope body with a 40x 1.15 NA water-immersion objective. Light-sheet imaging (Fig 2b) was performed with a Zeiss Z.1 Light-Sheet microscope, utilizing a 20x 1.0 NA water immersion lens.
Expansion Factor Measurement
To determine the expansion factor for all mExM experiments, two procedures were followed.
First, the distance between two landmarks in the whole tissue specimen was measured and compared before and after the expansion. Second, the tissue thickness, as measured by imaging the fluorescent labels across the vertical section of the specimen on a microscope, was determined and compared before and after expansion. The expansion factors that were obtained following these two ways were then averaged to be able to determine the expansion factor of an mExM experiment.
Image Processing
Images shown in Figures 2-3 were first filtered by a Gaussian filter, and then processed by the CLAHE algorithm 37 to remove possible noise. Image processing was performed with a 64GB RAM, 8 core CPU desktop. 
